FDA Unveils Vision for National Post-Market Device Surveillance

By MedTech Intelligence Staff

A recent report describes an ambitious national medical device monitoring system that harnesses novel data sources, modern analytical techniques and the participation of all stakeholders to optimize patient care.

A recent report describes an ambitious national medical device monitoring system that harnesses novel data sources, modern analytical techniques and the participation of all stakeholders to optimize patient care.

Continue reading

Cardinal to buy J&J’s Cordis Unit?

By MedTech Intelligence Staff

Bloomberg reports that the world’s largest healthcare company Johnson & Johnson is in talks with Cardinal Health Inc. to sell its Cordis unit. The unit may fetch as much as $2 billion in a sale, according to the story.

Bloomberg reports that the world’s largest healthcare company Johnson & Johnson is in talks with Cardinal Health Inc. to sell its Cordis unit. The unit may fetch as much as $2 billion in a sale, according to the story.

Continue reading

Medtronic Posts Higher-Than-Expected Q3 Profits

By MedTech Intelligence Staff

The company’s heart devices such as implantable defibrillators, artificial valves and devices to treat atrial fibrillation, contributed to a 5 percent increase in sales in the cardiac and vascular business, its largest unit.

The company’s heart devices such as implantable defibrillators, artificial valves and devices to treat atrial fibrillation, contributed to a 5 percent increase in sales in the cardiac and vascular business, its largest unit.

Continue reading

Med-tech Deal Activity Remained Strong in Q4

By MedTech Intelligence Staff

According to recent analysis by PwC, deal volume declined from 13 deals in the third quarter of 2014 to 9 deals in the fourth quarter. However, deal value increased from $3.7 billion to $4.9 billion over the same period.

According to recent analysis by PwC, deal volume declined from 13 deals in the third quarter of 2014 to 9 deals in the fourth quarter. However, deal value increased from $3.7 billion to $4.9 billion over the same period.

Continue reading

Overcoming Barriers to Improvement in Product Development

By MedTech Intelligence Staff

Despite a clear need to get better development lifecycle management solutions in place, companies are restricted by tight budgets, validation overhead, and bureaucracy. In this Q&A, Matt Harp and Angie Pepiot at Seapine Software share their insights.

Despite a clear need to get better development lifecycle management solutions in place, companies are restricted by tight budgets, validation overhead, and bureaucracy. In this Q&A, Matt Harp and Angie Pepiot at Seapine Software share their insights.

Continue reading

What Can Apps Do For Health?

By MedTech Intelligence Staff

Apps are being successfully used in the field of individual, community-related and company prevention – even if is only to help employees leading healthy lives for example. But which apps are actually worth recommending in the field of health? How good are these apps and what constitutes a good app?

Apps are being successfully used in the field of individual, community-related and company prevention – even if is only to help employees leading healthy lives for example. But which apps are actually worth recommending in the field of health? How good are these apps and what constitutes a good app?

Continue reading

Medical Device Supplier Certification: the Rx-360 Approach

By MedTech Intelligence Staff

Rx-360, an international pharmaceutical supply chain consortium, which helps its members share best practices to ensure the integrity of the healthcare supply chain, is now gearing for growth in the device space. What lessons can device makers learn?

Rx-360, an international pharmaceutical supply chain consortium, which helps its members share best practices to ensure the integrity of the healthcare supply chain, is now gearing for growth in the device space. What lessons can device makers learn?

Continue reading